Skip to main content
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
9.32
+0.19 (2.08%)
At close: Mar 9, 2026, 4:00 PM EDT
9.41
+0.09 (0.97%)
After-hours: Mar 9, 2026, 6:54 PM EDT

Seres Therapeutics Revenue

Seres Therapeutics had revenue of $351.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $351.00K.

Revenue (ttm)
$351.00K
Revenue Growth
n/a
P/S Ratio
235.96
Revenue / Employee
$3,408
Employees
103
Market Cap
84.31M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021144.93M111.71M336.33%
Dec 31, 202033.22M-1.29M-3.74%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 58.42M
Verrica Pharmaceuticals 30.83M
Pyxis Oncology 2.82M
Kazia Therapeutics 1.20M
iBio, Inc. 300.00K
aTyr Pharma 190.00K
Revenue Rankings

MCRB News

More News